Eligibility Criteria

Main Inclusion criteria:

• Written informed consent and able to comply with the protocol
• Histologically confirmed epithelial ovarian cancer, fallopian tube or primary peritoneal cancer
• Patients fit enough to receive protocol treatment

Main Exclusion criteria:

• Surgery (including open biopsy), or radiotherapy within the last 8 weeks
• Malignancies other than ovarian cancer within 5 years prior to randomisation, except for adequately treated carcinoma in situ of the cervix and/or basal cell skin cancer
• Uncontrolled hypertension
• Current or recent (within 10 days of first dose of study treatment) use of aspirin > 325 mg/day

For full listing of both inclusion and exclusion criteria please refer to section 6 of the protocol.